Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Roche develops RO-4929097 to target Notch for tumor growth inhibition

May 15, 2009

Nerviano Medical Sciences discloses novel anticancer agents under preclinical evaluation

May 14, 2009

LiPlasome describes activity of liposomal formulations of cisplatin, oxaliplatin

May 14, 2009

Data on MedImmune anticancer monoclonal antibodies MEDI-573, MEDI-3617 presented

May 14, 2009

Taiho claims novel retinoid RARalpha agonists as antitumor agents

May 14, 2009

Merck KGaA presents novel TGF-beta inhibitors for cancer treatment

May 14, 2009

FDA approves Nerviano's IND to initiate phase I clinical trial of cancer drug PLK-1

May 14, 2009

Phase I trial of EC-0489 for refractory or metastatic solid tumors begins

May 14, 2009

FDA accepts Arno's IND for the use of AR-12 in adults with solid tumors or lymphoma

May 13, 2009

Monoclonal antisera against fibroblast growth factor-2 or its receptor show antineoplastic activity

May 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...